FDA Inspection 1232210 — Genzyme Corporation
The FDA completed an inspection of Genzyme Corporation on Jul 9, 2024 in Framingham, MA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jul 9, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Framingham, MA (United States)